Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to study if aspirin and statins (lipid-lowering agents) can reduce the progression of subclinical atherosclerosis in patients with systemic lupus erythematosus (SLE).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Tuen Mun Hospital
Collaborators
NCT07350499 · Arterial Thromboembolism, Venous Thromboembolism, and more
NCT07371468 · Systemic Lupus Erythematosus
NCT07613294 · Atherosclerosis, Cardiovascular Diseases, and more
NCT05867381 · Air Pollution, Atherosclerosis
NCT07617740 · REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Tuen Mun Hospital
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions